Your browser doesn't support javascript.
loading
EGFR T790M mutation testing within the osimertinib AURA Phase I study.
Dearden, Simon; Brown, Helen; Jenkins, Suzanne; Thress, Kenneth S; Cantarini, Mireille; Cole, Rebecca; Ranson, Malcolm; Jänne, Pasi A.
Afiliação
  • Dearden S; Personalised Healthcare & Biomarkers, AstraZeneca, Cambridge, UK. Electronic address: Simon.Dearden@astrazeneca.com.
  • Brown H; Personalised Healthcare & Biomarkers, AstraZeneca, Cambridge, UK. Electronic address: Helen.Brown3@astrazeneca.com.
  • Jenkins S; Personalised Healthcare & Biomarkers, AstraZeneca, Macclesfield, UK. Electronic address: Suzanne.Jenkins@astrazeneca.com.
  • Thress KS; Translational Science, Oncology iMED, AstraZeneca, Waltham, MA, USA. Electronic address: Kenneth.Thress@astrazeneca.com.
  • Cantarini M; Global Medicines Development, AstraZeneca, Macclesfield, UK. Electronic address: Mireille.Cantarini@astrazeneca.com.
  • Cole R; Formerly of Early Clinical Development, AstraZeneca, Macclesfield, UK. Electronic address: rebeccaecole@yahoo.co.uk.
  • Ranson M; Formerly of Medical Oncology, Clinical Pharmacology and Lung Cancer, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: malcolm.ranson2@btinternet.com.
  • Jänne PA; Lowe Center for Thoracic Oncology and the Belfer Center for Applied Cancer Science, Dana Farber Cancer Institute, Boston, MA, USA. Electronic address: Pasi_Janne@dfci.harvard.edu.
Lung Cancer ; 109: 9-13, 2017 07.
Article em En | MEDLINE | ID: mdl-28577957
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans País como assunto: America do norte / Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans País como assunto: America do norte / Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article